Skip to main content
SpringerLink
Log in

AAN-Kongress 2019 in Philadelphia

Attraktive Aussicht auf hochspezifische Therapien

  • aktuell
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

Auf dem Kongress der American Academy of Neurology wurden vom 4.–10. Mai 2019 erste klinische Studien zu hochspezifischen, wirksamen Therapien für Patienten mit Bewegungsstörungen vorgestellt und Laborparameter zur Verlaufsbewertung der MS diskutiert.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1
2
1

Literatur

  • American Academy of Neurology Annual Meeting, Philadelphia, USA, 4.–10.5.2019 Scientific Session S4: Clinical Trials in Movement Disorders, Clinical Trial Plenary Session

  • American Academy of Neurology Annual Meeting, Philadelphia, USA, 4.–10.5.2019

  • American Academy of Neurology Annual Meeting, Philadelphia, USA, 4.–10.5.2019; Clinical Trials Plenary Session

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Thomas Müller (freier Medizinjournalist) & Thomas M. Heim (freier Wissenschaftsjournalist)

Authors
  1. Thomas Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas M. Heim
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Müller, T., Heim, T.M. Attraktive Aussicht auf hochspezifische Therapien. InFo Neurologie 21, 66–70 (2019). https://doi.org/10.1007/s15005-019-0109-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-019-0109-z

Search

Navigation